BNP Paribas Asset Management
ABUS icon

BNP Paribas Asset Management’s Arbutus Biopharma ABUS Stock Holding History

BNP Paribas Asset Management’s Portfolio ABUS Stock Details ABUS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$16.9K Buy
3,766
+1,367
+57% +$5.98K ﹤0.01% 2081
2025
Q4 		$12K Buy
2,399
+468
+24% +$2.1K ﹤0.01% 2084
2025
Q3 		$9K Buy
1,931
+175
+10% +$643 ﹤0.01% 1654
2025
Q2 		$5K Buy
+1,756
New +$5.83K ﹤0.01% 1967
2015
Q3 		– Sell
-212,934
Closed -$2.52M – 1006
2015
Q2 		$2.52M Sell
212,934
-121,241
-36% -$1.85M 0.02% 659
2015
Q1 		$5.83M Buy
+334,175
New +$6.85M 0.04% 442

Other funds holding ABUS

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $7.15B AUM 169.27% 1-Year Est. Return
WCM
Whitefort Capital Management New York $339M AUM 52.48% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return

BNP Paribas Asset Management's ABUS Position: Q1 2026 in Review

BNP Paribas Asset Management increased its Arbutus Biopharma (ABUS) stake by 57% in Q1 2026, buying an estimated $5.98K and bringing the position to 3,766 shares worth $16.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2081.

BNP Paribas Asset Management first reported a position in ABUS in Q1 2015 and has held it in 6 quarters since. The position peaked at $5.83M in Q1 2015. 167 funds tracked by Wall St. Rank hold ABUS as of Q1 2026.

  • BNP Paribas Asset Management held 3,766 shares of Arbutus Biopharma worth $16.9K as of Q1 2026.
  • BNP Paribas Asset Management bought 1,367 Arbutus Biopharma shares in Q1 2026, an estimated $5.98K.
  • Arbutus Biopharma made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q1 2026, its #2081 holding.
  • BNP Paribas Asset Management first reported a position in Arbutus Biopharma in Q1 2015 and has held it in 6 quarters since.
  • BNP Paribas Asset Management's Arbutus Biopharma position peaked at $5.83M in Q1 2015.
  • 167 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q1 2026.

Based on BNP Paribas Asset Management's 13F filing for Q1 2026, filed 14 May 2026.